In case of CVD + Cancer + CDK + COVID-19, the drugs and targets were lapatinib, gefitinib for EGFR, prednisolone for IL6, and AZD-1480, currently in a phase I/II trial for STAT3. This evidence concerns the gene EGFR and cancer.